• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梅内特里耶病:临床综述。

Ménétrier disease: A clinical review.

作者信息

Barros Ana R, Monteiro Sara, Silva Jorge

机构信息

Department of Gastroenterology, Unidade Local de Saúde Tâmega e Sousa, Penafiel 4560-136, Porto, Portugal.

出版信息

World J Gastroenterol. 2025 Aug 28;31(32):108401. doi: 10.3748/wjg.v31.i32.108401.

DOI:10.3748/wjg.v31.i32.108401
PMID:40900775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12400214/
Abstract

Ménétrier disease (MD) is a rare gastric disorder characterized by hypertrophy of the gastric mucosa, resulting in giant gastric folds, excessive mucus secretion, and significant protein loss. It is most common in middle-aged males, although cases have also been reported in children. This condition, also known as hyperplastic hypersecretory gastropathy, primarily affects the fundus and body of the stomach, leading to protein-losing gastropathy due to increased mucosal permeability. The exact pathogenesis of MD remains unclear; however, it has been linked to excessive transforming growth factor-alpha signaling the epidermal growth factor receptor (EGFR), which promotes mucosal hyperplasia. Clinical manifestations include epigastric pain, nausea, vomiting, anorexia, weight loss, and peripheral edema due to protein-losing enteropathy. Diagnosis is based on clinical presentation, endoscopic findings, and histopathology revealing foveolar hyperplasia and glandular atrophy. Treatment options vary from symptomatic management with proton pump inhibitors and nutritional support to monoclonal antibodies targeting EGFR (, cetuximab) in severe cases. In refractory situations, gastrectomy may be required. This review highlights the current understanding, diagnostic approaches, and therapeutic strategies for MD.

摘要

门脉性胃病(MD)是一种罕见的胃部疾病,其特征为胃黏膜肥大,导致巨大胃皱襞、黏液分泌过多以及大量蛋白质丢失。该病在中年男性中最为常见,不过儿童病例也有报道。这种病症,也被称为增生性高分泌性胃病,主要影响胃底和胃体,由于黏膜通透性增加导致蛋白丢失性胃病。MD的确切发病机制尚不清楚;然而,它与转化生长因子-α信号过度激活表皮生长因子受体(EGFR)有关,EGFR会促进黏膜增生。临床表现包括上腹部疼痛、恶心、呕吐、厌食、体重减轻以及因蛋白丢失性肠病导致的外周水肿。诊断基于临床表现、内镜检查结果以及组织病理学显示的小凹增生和腺体萎缩。治疗方案从使用质子泵抑制剂进行对症治疗和营养支持到在严重病例中使用靶向EGFR的单克隆抗体(如西妥昔单抗)不等。在难治性情况下,可能需要进行胃切除术。本综述重点介绍了目前对MD的认识、诊断方法和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/62a2b97e832a/wjg-31-32-108401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/1cebc3841ca6/wjg-31-32-108401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/e2391da8fce6/wjg-31-32-108401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/d237762b2ef6/wjg-31-32-108401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/62a2b97e832a/wjg-31-32-108401-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/1cebc3841ca6/wjg-31-32-108401-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/e2391da8fce6/wjg-31-32-108401-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/d237762b2ef6/wjg-31-32-108401-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d55/12400214/62a2b97e832a/wjg-31-32-108401-g004.jpg

相似文献

1
Ménétrier disease: A clinical review.梅内特里耶病:临床综述。
World J Gastroenterol. 2025 Aug 28;31(32):108401. doi: 10.3748/wjg.v31.i32.108401.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Ménétrier Disease: Rare Manifestations and Mechanistic Insights From 2 Adult Cases.梅内特里耶病:2例成人病例的罕见表现及机制见解
Am J Case Rep. 2025 Sep 1;26:e949111. doi: 10.12659/AJCR.949111.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
From Chronic Anemia to Total Gastrectomy: A Case Report on a Challenging Form of Ménétrier's Disease.从慢性贫血到全胃切除术:一例疑难型胃黏膜巨肥症的病例报告
Cureus. 2025 Jul 25;17(7):e88724. doi: 10.7759/cureus.88724. eCollection 2025 Jul.
6
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
7
Pharmacological treatment of children with gastro-oesophageal reflux.胃食管反流患儿的药物治疗
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD008550. doi: 10.1002/14651858.CD008550.pub2.
8
Development of Mouse Models for Ménétrier's Disease.门脉性胃病小鼠模型的建立。
J Vis Exp. 2025 Jun 6(220). doi: 10.3791/67981.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

本文引用的文献

1
Helicobacter pylori and gastric cancer: mechanisms and new perspectives.幽门螺杆菌与胃癌:机制及新观点
J Hematol Oncol. 2025 Jan 23;18(1):10. doi: 10.1186/s13045-024-01654-2.
2
Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance.奥希替尼耐药的表皮生长因子受体突变型非小细胞肺癌患者的治疗策略。
J Hematol Oncol. 2022 Dec 8;15(1):173. doi: 10.1186/s13045-022-01391-4.
3
Menetrier's disease exacerbating ulcerative colitis and relieved by gastrectomy.胃大部切除术后缓解的并发溃疡性结肠炎的巨大肥厚性胃炎。
BMJ Open Gastroenterol. 2021 Dec;8(1). doi: 10.1136/bmjgast-2021-000806.
4
Strategies to Target ADAM17 in Disease: From its Discovery to the iRhom Revolution.靶向 ADAM17 的疾病治疗策略:从发现到 iRhom 革命。
Molecules. 2021 Feb 10;26(4):944. doi: 10.3390/molecules26040944.
5
Diagnosis and Management of Ménétrier Disease in Children: A Case Series Review.儿童胃黏膜巨肥厚症的诊断与管理:病例系列回顾
Pediatr Gastroenterol Hepatol Nutr. 2021 Jan;24(1):109-117. doi: 10.5223/pghn.2021.24.1.109. Epub 2021 Jan 8.
6
Role of Octreotide in Menetrier's Disease: Case Report and Review of Literature.奥曲肽在梅内特里耶病中的作用:病例报告及文献综述
Cureus. 2020 Nov 16;12(11):e11515. doi: 10.7759/cureus.11515.
7
Total gastrectomy for the treatment of Menetrier's disease persistent to medical therapy: A case report.全胃切除术治疗内科治疗无效的梅内特里耶病:一例报告
Int J Surg Case Rep. 2020;73:95-99. doi: 10.1016/j.ijscr.2020.06.033. Epub 2020 Jun 30.
8
Survival Times of Patients With Menetrier's Disease and Risk of Gastric Cancer.梅内特里耶病患者的生存时间与胃癌风险
Clin Gastroenterol Hepatol. 2021 Apr;19(4):707-712. doi: 10.1016/j.cgh.2020.03.017. Epub 2020 Mar 14.
9
Ménétrier's disease : a case of successful treatment using long-acting octreotide.梅内特里耶病:一例使用长效奥曲肽成功治疗的病例。
Acta Gastroenterol Belg. 2019 Jul-Sep;82(3):429-432.
10
A case of Ménétriere´s disease treated with the monoclonal antibody cetuximab.1例用单克隆抗体西妥昔单抗治疗的胃黏膜巨肥厚症病例。
Clin J Gastroenterol. 2019 Dec;12(6):562-565. doi: 10.1007/s12328-019-00994-8. Epub 2019 May 23.